The Tuberculosis Drug Accelerator at year 10: what have we learned?

The Tuberculosis Drug Accelerator, an experiment designed to facilitate collaboration in tuberculosis drug discovery by breaking down barriers among competing labs and institutions, has reached a 10-year landmark. We review the consortium’s achievements, advantages and limitations and advocate for the application of similar models to other diseases. Read here
6 views0 comments

Recent Posts

See All

WHO 2021 Genetic Susceptibility Testing Statement

This document summarizes the WHO’s review of various diagnostics for TB. Most of it is not new, but important additions are evaluation of molecular methods for detection of resistance to INH (pages 50


Active TB Drug Safety Monitoring and Management (aDSM) global database: Outcome of the assessment and future of data reporting. Read here.